Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease

Dorota Drożdż1, Przemko Kwinta2, Krystyna Sztefko3

  • 1Dialysis Unit, Jagiellonian University Medical College, 265 Wielicka Street, 30-663 Krakow, Poland.

Insights

Oxidized low-density lipoprotein (oxLDL) levels are linked to cardiovascular risks and left ventricular hypertrophy in children with chronic kidney disease (CKD). These findings highlight oxLDL as a key marker for oxidative stress in pediatric CKD patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Oxidative Stress Biomarkers

Background:

  • Cardiovascular diseases are a leading cause of death in children with chronic kidney disease (CKD).
  • Oxidative stress plays a significant role in the development of cardiovascular complications in CKD.
  • Left ventricular hypertrophy (LVH) is a common cardiovascular manifestation in pediatric CKD.

Purpose of the Study:

  • To investigate the association between oxidative stress biomarkers and cardiovascular risk factors.
  • To assess the relationship between oxidative stress and left ventricular hypertrophy (LVH) in children with CKD.
  • To evaluate the utility of serum oxidized low-density lipoprotein (oxLDL) as a marker in this population.

Main Methods:

  • Studied 65 children (ages 1.4-18.6 years) with stages 1-5 CKD.
  • Measured serum levels of oxLDL, protein carbonyls, creatinine, cystatin C, lipids, hs-CRP, ICAM-1, insulin, PRA, and aldosterone.
  • Performed anthropometric measurements, ambulatory blood pressure monitoring, and echocardiography for left ventricular mass (LVM) calculation.

Main Results:

  • Serum oxLDL showed significant correlations with creatinine, cystatin C, total cholesterol, triglycerides, and LDL concentrations.
  • Elevated oxLDL levels were strongly associated with 24-hour systolic, diastolic, and mean arterial blood pressure.
  • A significant correlation was observed between oxLDL levels and left ventricular mass (LVM) z-scores.

Conclusions:

  • Hypertension and dyslipidemia are linked to lipid oxidation in pediatric CKD.
  • Serum oxLDL is a valuable biomarker for oxidative stress in children with CKD.
  • Oxidative stress, indicated by oxLDL, correlates with left ventricular hypertrophy in this patient group.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
737
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K